e and other new drugs that have hit the market or on the verge of FDA ... People respond differently to different therapies he said. The mor...The new oral therapies also help people regain some small sense of con... It's certainly a more convenient form of the type of therapy that's a...With the approval of the new drugs eyes are turning toward the future...

e and other new drugs that have hit the market or on the verge of FDA approval will make it much easier for those with MS to find relief.

"People respond differently to different therapies," he said. "The more treatments we have, the higher the likelihood that a person will find a treatment that works best for them. We're going to see a steady stream of options for people with MS, providing people with the choices they need."

The new oral therapies also help people regain some small sense of control by allowing them to more easily take their medications, said Dr. Ron Cohen, chief executive and founder of Acorda Therapeutics, the company that developed Ampyra.

"It's certainly a more convenient form of the type of therapy that's already been available as an injection," Cohen said. "What's not known right now is, of all the orals, the relative efficacy of these orals versus the best of the injectables. With the injectables, there's a pretty good sense of what to expect in terms of efficacy and safety. It will take several years to develop such a track record for oral medications."

With the approval of the new drugs, eyes are turning toward the future and the next potential advance in MS treatment. Both Cohen and LaRocca said that treatments that repair the neural damage caused by multiple sclerosis are the next frontier for researchers.

Multiple sclerosis is now believed to be an autoimmune disorder in which the body damages the nervous system by attacking myelin, the fatty substance that surrounds and protects nerve fibers, according to the National Multiple Sclerosis Society.

The drug Ampyra works by restoring the conductive power of nerves that have lost their myelin, Cohen said.

"Right now, there's nothing that can repair the damage once it's been done," he said. "If we had something that could restore the myelin, you could potentially dial back the damage done by the disease."

(Date:3/3/2015)... The number of couples experiencing infertility in ... This increases to 50% by the time a woman ... AA, et al. Estimating the prevalence of infertility in ... a reproductive endocrinologist and co-director at Olive Fertility Centre, ... director and founder of Acubalance Wellness Centre will be ...

(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...

(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...

(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...

... 1 An independent study at the,University of Cumbria found that ... same time as exercising. The games reduce the boredom of,exercise. , ... 12 were asked to use exercise equipment,combined with video games provided ... The children could play their games only while they maintained ...

... can prevent spread of infection , , MONDAY, Dec. 1 (HealthDay ... and older for HIV, says a new practice guideline released ... the virus that causes AIDS. , In the United ... 20,000 new infections are caused each year by people who ...

... Acuo Technologies(R), developers,of high-performance software for intelligent ... announced the contracting with Rush,University Medical ... neutral archiving,solution which becomes the basis of the ... is based on the Acuo Technologies DICOM,Services Grid(TM) ...

... board of directors of Eli Lilly and Company (NYSE: LLY ... $0.49 a share on outstanding common stock. This is the same dividend ... the total annual dividend for 2011 to $1.96 per share. ... the close of business on November 15, 2011. About ...